Synthesis and anti-Mycobacterium tuberculosis evaluation of aza-stilbene derivatives

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1113-1119

  Pavan, Fernando R ^a   De Carvalho, Gustavo Senra G ^b   Da Silva, Adilson D ^b   Leite, Clarice Q F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Aza stilbene derivatives; New drugs; Stilbenes; Tuberculosis

Indexed keywords

PYRAZINAMIDE; STILBENE DERIVATIVE; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; STRUCTURE ACTIVITY RELATION; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; STILBENES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79958159296     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.110     Document Type: Article

References (44)

1. (2009) Scientific Blueprint for TB Drug Development. Global Alliance for TB Drug Development, New York. pp. 26-28.
2. (2009) The Global Plan to Stop TB 2006-2015: Progress Report 2006-2008. World Health Organization, Geneva. p. 8.
3. Gandhi, N.R., Nunn, P., Dheda, K., Schaaf, H.S., Zignol, M., Soolingen, D.V., Jensen P., and Bayona, J. (2010) Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375, 1830-1843.
4. MÉDICINS SANS FRONTIÈRES: http://www.msf.ch/fileadmin/user- upload/uploads/rapports/2006-10-30-tb/TBPipeline.pdf, acessed September 13, 2010.
5. Chong, J., Poutaraud, A., and Hugueney, P. (2009) Metabolism and roles of stilbenes in plants. Plant Sci. 177, 143-155.
6. Robert, M., Pizzirani, D., Recanatini, M., Simoni, D., Grimaudo, S., Cristina, A.D., Abbadessa, V., Gebbia, N., and Tolomeo, M. (2006) Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. J. Med. Chem. 49, 3012-3018.
7. Breinbauer, R., Vetter, I.R., and Waldmann, H. (2002) From protein domains to drug candidates - natural products as guiding principles in compound library design and synthesis. Angew. Chem. Int. Ed. Engl. 41, 2878-2890. (Pubitemid 34966550)
8. Baur, J.A. and Sinclair, D.A. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493-506. (Pubitemid 44136961)
9. Renaud, S. and De Lorgeril, M. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526.
10. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, K.G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K.W., Spencer, R.G., Lakatta, E.G., Couter, D.L., Shaw, R.J., Navas, P., Puigserver, P., Ingram, D.K., de Cabo, R., and Sinclair, D.A. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342. (Pubitemid 44764104)
11. Kimura, Y., Okuda, H., and Arichi, S. (1985) Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim. Biophys. Acta 834, 275-278. (Pubitemid 15072791)
12. Park, E.J., Min, H.Y., Ahn, Y.H., Bae, C.M., Pyee, J.H., and Lee, S.K. (2004) Synthesis and inhibitory effects of pinosylvin derivatives on prostaglandin E2 production in lipopolysaccharide-induced mouse macrophage cells. Bioorg. Med. Chem. Lett. 14, 5895-5898.
13. Heynekamp, J.J., Webwe, W.M., Hunsker, L.A., Gonzales, A.M., and Orlando, R.A. (2006) Substituted trans-stilbenes, including analogs of the natural product resveratrol, Inhibit the tumor necrosis factor-alpha-induced activation of nuclear factor-kappaB. J. Med. Chem. 49, 7182-7189. (Pubitemid 44886003)
14. Lion, C.J., Matthews, C.S., Stevens, M.F.G., and Westwell, A.D. (2005) Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes. J. Med. Chem. 48, 1292-1295. (Pubitemid 40270477)
15. Botella, L. and Nájara, C. (2004) Synthesis of methylated resveratrol and analogues by Heck reactions in organic and aqueous solvents. Tetrahedron 60, 5563-5570. (Pubitemid 38759336)
16. Velder, J., Ritter, S., Lex, J., and Schmalz, H.G. (2006) A simple access to biologically important trans-stilbenes via Ru-catalyzed cross metathesis. Synthesis 2, 273-278. (Pubitemid 43164412)
17. Jang, D.S., Kang, B.S., Ryu, S.Y., Chang, I.M., Min, K.E., and Kim, Y. (1999) Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem. Pharmacol. 57, 705-712. (Pubitemid 29080762)
18. Gupta, Y.K., Chaudhary, G., and Srivastava, A.K. (2002) Protective effect of resveratrol against pentylenetetrazole-induced seizures and its modulation by an adenosinergic system. Pharmacology 65, 170-174. (Pubitemid 34621753)
19. Docherty, J.J., Fu, M.M.H., Stifler, B.S., Limporos, R.J., Pokabla, C.M., and Delucia, A.L. (1999) Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 43, 135-145.
20. Chen, G., Shan, W., Wu, Y., Ren, L., Dong, J., and Ji, Z. (2005) Synthesis and anti-inflammatory activity of resveratrol analogs. Chem. Pharm. Bull. 53, 1587-1590. (Pubitemid 41744490)
21. Sundar, I. and Chang, F.N. (1992) The role of guanosine-3′, 5′-bis-pyrophosphate in mediating antimicrobial activity of the antibiotic 3,5-dihydroxy-4-ethyl-trans-stilbene. Antimicrob. Agents Chemother. 36, 2645-2651.
22. Subramanian, M., Shadakshari, U., and Chattopadhyay, S. (2004) A mechanistic study on the nuclease activities of some hydroxystilbenes. Bioorg. Med. Chem. 12, 1231-1237. (Pubitemid 38251314)
23. Kabir, M.S., Engelbrecht, K., Polanowski, R., Krueger, S.M., Ignasiak, R., Rott, M., Schwan, W.R., Stemper, M.E., Reed, K.D., Sherman, D., Cook, J.M., and Monte, A. (2008) New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. Bioorg. Med. Chem. Lett. 18, 5745-5749.
24. Skretas, G., Meligova, A.K., Villalonga-Barber, C., Mitsiou, D.J., Alexis, M.N., Micha-Screttas, M., Steele, B.R, Screttas, C.G., and Wood, D.W. (2007) Engineered chimeric enzymes as tools for drug discovery: generating reliable bacterial screens for the detection, discovery, and assessment of estrogen receptor modulators. J. Am. Chem. Soc. 129, 8443-8457. (Pubitemid 47066506)
25. Lechner, D., Gibbons, S., and Bucar, F. (2008) Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J. Antimicrob. Chemother. 62, 345-348. (Pubitemid 351984778)
26. Guiso, M., Marra, C., and Farina, A. (2002) A new efficient resveratrol synthesis. Tetrahedron Lett. 43, 597-598. (Pubitemid 34085022)
27. Kim, S., Ko, H., Park, J.E., Jung, S., Lee, S.K., and Chun, Y.J. (2002) Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. J. Med. Chem. 45, 160-164. (Pubitemid 34038551)
28. Patani, G.A. and Lavoie, E.J. (1996) Bioisosterism: a rational approach in drug design. Chem. Rev. 96, 3147-3176. (Pubitemid 126641132)
29. Pavan, F.R., Poelhsitz, G.V., do Nascimento, F.B., Leite, S.R.A., Batista, A.A., Deflon, V.M., Sato, D.N., Franzblau, S.G., and Leite, C.Q.F. (2010) Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents. Eur. J. Med. Chem. 45, 598-601.
30. Pavan, F.R., Maia, P.I.S., Leite, S.R.A., Deflon, V.M., Batista, A.A., Sato, D.N., Franzblau, S.G., and Leite, C.Q.F. (2010) Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity. Eur. J. Med. Chem. 45, 1898-1905.
31. Honda, N.K., Pavan, F.R., Coelho, R.G., Leite, S.R.A., Micheletti, A.C., Lopes, T.I.B., Misutsy, M.Y., Beatriz, A., Brum, R.L., and Leite, C.Q.F. (2010) Antimycobacterial activity of lichen substances. Phytomedicine (Stuttgart) 17, 328-332.
32. Maia, P.I.S., Graminha, A., Pavan, F.R., Leite, C.Q.F., Batista, A.A., Lang, E.S., Ellena, J., Lemos, S.S., Salistre-de-Araujo, H.S., and Deflon, V.M. (2010) Palladium(II) complexes with thiosemicarbazones. Syntheses, characterization and cytotoxicity against breast cancer cells and anti-Mycobacterium tuberculosis activity. J. Braz. Chem. Soc. 21, 1117-1186.
33. Tarallo, M.B., Urquiola, C., Monge, A., Costa, B.P., Ribeiro, R.R., Costa-Filho, A.J., Mercarder, R.C., Pavan, F.R., Leite, C.Q.F., and Torre, M.H. (2010) Design of novel iron compounds as potential therapeutic agents against tuberculosis. J. Inorg. Biochem. 104, 1164-1170.
34. de Souza, R.A., Stevanato, A., Treu-Filho, O., Netto, A.V.G., Mauro, A.E., Castellano, E.E., Carlos, I.Z., Pavan, F.R., and Leite, C.Q.F. (2010) Antimycobacterial and antitumor activities of Palladium(II) complexes containing isonicotinamide (isn): X-ray structure of trans-[Pd(N3)2(isn)2]. Eur. J. Med. Chem. 45, 4863-4868.
35. Moro, A.C., Mauro, A.E., Netto, A.V.G., Ananias, S.R., Quilles, M.B., Carlos, I.Z., Pavan, F.R., Leite, C.Q.F., and Horner, M. (2009) Antitumor and antimycobacterial activities of cyclopalladated complexes: X-ray structure of[Pd(C2,N-dmba)(Br)(tu)] (dmba = N,N-dimethylbenzylamine, tu = thiourea). Eur. J. Med. Chem. 44, 4611-4615.
36. Pavan, F.R., Leite, C.Q.F., Coelho, R.G., Coutinho, I.D., Honda, N.K., Cardoso, C.A.L., Vilegas, W., Leite, S.R.A., and Sato, D.N. (2009) Evaluation of anti-Mycobacterium tuberculosis activity of Campomanesia adamantium (Myrtaceae). Quim. Nova 32, 1222-1226.
37. Palomino, J.C., Martin, A., Camacho, M., Guerra, H., Swings, J., and Portaels, F. (2002) Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46, 2720-2722. (Pubitemid 34793497)
38. Collins, L.A. and Franzblau, S.G. (1997) Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 2, 1004-1009. (Pubitemid 27194176)
39. Cheng, L.-X., Tang, J.-J., Luo, H., Jin, X.-L., Dai, F., Yang, J., Qian, Y.-P., Li, X.-Z., and Zhou, B. (2010) Antioxidant and antiproliferative activities of hydroxyl-substituted Schiff bases. Bioorg. Med. Chem. Lett. 20, 2417-2420.
40. Manchot, W. (1912) Über Phenol- und Chinonisomerie bei den Schiffschen Basen aromatischer Oxyaldehyde. Justus Liebigs Ann. Chem. 388, 103-135.
41. Ritter, D.M. (1947) Oxidation potentials of some compounds related to vanillin. J. Am. Chem. Soc. 69, 46-50.
42. Senier, A. and Forster, R.B. (1915) Studies in phototropy and thermotropy. Part VII. Polymorphic anisylidenearylamines produced by trituration and by the influence of actinic light. J. Chem. Soc. Perkin Trans. I 107, 1168-1173.
43. Manrao, M.R., Kanta, C., Sharma, R.C., Kalsi, P.S., and Kaul, V.K. (1995) Synthesis and biological studied of 3,4,5-trimethoxy benzalanilines. Asian J. Chem. 7, 27-32.
44. (2008) Handbook for Antituberculosis Agents. Global Alliance for TB Drug Development, New York. pp. 141-144.